The important role of histone deacetylases in modulating vascular physiology and arteriosclerosis

Ting C Zhao1, Zhengke Wang2, Tina Y Zhao3

  • 1Department of Surgery and Plastics Surgery, Brown University, Rhode Island Hospital, Providence, RI, USA.

Atherosclerosis
|June 15, 2020
PubMed

Insights

Histone deacetylases (HDACs) regulate gene transcription in cardiovascular disease. Selective HDAC inhibitors show promise for preventing cardiac hypertrophy and treating vascular dysfunction.

Area of Science:

  • Cardiovascular biology
  • Epigenetics
  • Molecular medicine

Background:

  • Cardiovascular diseases are a leading global cause of mortality.
  • Endothelial dysfunction and inflammation drive atherosclerotic lesion development.
  • Histone deacetylases (HDACs) are critical epigenetic regulators in cardiovascular pathology.

Purpose of the Study:

  • To review the role of HDACs in vascular cell function.
  • To discuss the therapeutic potential of HDAC inhibitors in cardiovascular disease.
  • To explore the molecular mechanisms underlying HDAC regulation in the vasculature.

Main Methods:

  • Literature review of cellular and molecular mechanisms.
  • Analysis of HDACs' co-regulatory networks and protein targets.
  • Examination of pharmacologic interventions targeting HDACs.

Main Results:

  • HDACs play a significant role in the epigenetic regulation of gene transcription in response to vascular stress.
  • HDACs form complex networks with transcription factors, influencing vascular system regulation.
  • Selective HDAC inhibitors are identified as promising therapeutic targets, particularly for cardiac hypertrophy.

Conclusions:

  • HDACs are key mediators of biological functions in vascular cells.
  • Targeting HDACs offers a promising strategy for managing cardiovascular diseases.
  • Further research into HDACs and their inhibitors is crucial for developing effective vascular disease treatments.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
259
Histone Modification02:32

Histone Modification

The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
15.6K
Histone Modification02:32

Histone Modification

4.2K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
599
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
633